Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 58Breast Neoplasms 25Neoplasms 5Neoplasm Metastasis 3Leiomyoma 3Polycystic Ovary Syndrome 2Neoplasms by Site 2Endometrial Neoplasms 2Cardiovascular Diseases 2Breast Diseases 2Stage II Prostate Adenocarcinoma 1Sleep Wake Disorders 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Pelvic Pain 1Ovarian Neoplasms 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Kallmann Syndrome 1Inflammatory Breast Neoplasms 1

Interventions

Uterine Myomectomy 1Uterine Artery Embolization 1Salpingectomy 1Gonadotropin-Releasing Hormone 1Diathermy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pelvic Pain × Gonadotropin-Releasing Hormone × Clear all
NCT02086279 2014-11-25

AMH Levels Change During Treatment With GnRh Agonist

University Magna Graecia

Phase NA Completed
67 enrolled

Endometriosis, Leiomyoma, Pelvic Pain, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡